Effect of pharmacist involvement in Diabetes Medication Therapy Adherence Program (DMTAC) on the clinical outcomes of diabetes in two different hospitals of Kedah state Malaysia
Not Applicable
- Conditions
- Diabetes mellitusMetabolic and Endocrine - Diabetes
- Registration Number
- ACTRN12621001128886
- Lead Sponsor
- Muhammad Zahid Iqbl
- Brief Summary
This section not yet completed
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Stopped early
- Sex
- All
- Target Recruitment
- 299
Inclusion Criteria
Patients who are having Diabetes mellitus since a minimum of 5 years and HbA1c more than 8.0% and receiving medicine from any selected hospital. Total 200 patients required in each selected hospital and from those 200 patients 100 will be taken from Diabetic clinics and 100 will be taken from DMTAC clinics
Exclusion Criteria
Pregnant diabetic patients, HIV / cancer patients, Incomplete Patient Record,Children with CKD, Newly diagnosed patients
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the impact of pharmacist intervention on clinical outcomes in the form of HbA1c of diabetes mellitus in diabetic patients.<br><br>Hospital laboratories determined the HbA1c of patients in both study groups as both the selected study hospitals belonged to the government; thus, the laboratory investigations and all medications were provided by the government of Malaysia under the Ministry of Health Malaysia. All the laboratory investigations and medicines are free of cost to the patients. The researchers only collected the details of data in the form of information from the patients. Additionally, the study tool also carried various signs and symptoms list related to diabetic neuropathy to evaluate diabetic complications in selected patients. [Approximately one year after the patient recruitment ]
- Secondary Outcome Measures
Name Time Method